These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Balloon-occluded retrograde transvenous obliteration (BRTO) for a direct shunt between the inferior mesenteric vein and the inferior vena cava in a patient with hepatic encephalopathy. Ibukuro K, Sugihara T, Tanaka R, Fukuda H, Abe S, Tobe K, Tateishi R, Tagawa K. J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):121-5. PubMed ID: 17296712 [Abstract] [Full Text] [Related]
3. Hepatic encephalopathy secondary to intrahepatic portosystemic venous shunt: balloon-occluded retrograde transvenous embolization with n-butyl cyanoacrylate and microcoils. Yamagami T, Nakamura T, Iida S, Kato T, Tanaka O, Matsushima S, Ito H, Okuyama C, Ushijima Y, Shiga K, Nishimura T. Cardiovasc Intervent Radiol; 2002 Jan; 25(3):219-21. PubMed ID: 12058220 [Abstract] [Full Text] [Related]
4. Portal-systemic shunt between the inferior mesenteric vein and inferior vena cava in a patient with hepatic encephalopathy: successful occlusion by balloon-occluded retrograde transvenous obliteration. Kakizawa H, Toyota N, Hieda M, Ishikawa M, Tanitame K, Tani C, Okazaki A, Takaki S, Aikata H, Chayama K, Awai K. Hiroshima J Med Sci; 2011 Mar; 60(1):15-9. PubMed ID: 21675043 [Abstract] [Full Text] [Related]
5. Treatment of hepatic encephalopathy due to inferior mesenteric vein/inferior vena cava and gonadal vein shunt using dual balloon-occluded retrograde transvenous obliteration. Tanaka R, Ibukuro K, Abe S, Tobe K, Fukuda H, Kondou Y, Tagawa K. Cardiovasc Intervent Radiol; 2009 Mar; 32(2):390-3. PubMed ID: 18839245 [No Abstract] [Full Text] [Related]
8. Intraperitoneal bleeding after balloon-occluded retrograde transvenous obliteration: a case report. Furue Y, Hidaka H, Fujii K, Matsunaga K, Koizumi W. J Med Case Rep; 2015 Mar 20; 9():62. PubMed ID: 25886049 [Abstract] [Full Text] [Related]
9. Successful portal-systemic shunt occlusion with balloon-occluded retrograde transvenous obliteration for portosystemic encephalopathy without liver cirrhosis. Tanaka O, Ishihara K, Oyamada H, Harusato A, Yamaguchi T, Ozawa M, Nakano K, Yamagami T, Nishimura T. J Vasc Interv Radiol; 2006 Dec 20; 17(12):1951-5. PubMed ID: 17185692 [Abstract] [Full Text] [Related]
11. Balloon-occluded retrograde transvenous obliteration for a portosystemic shunt after pediatric living-donor liver transplantation. Shigeta T, Kasahara M, Sakamoto S, Fukuda A, Kakiuchi T, Matsuno N, Tanaka H, Miyazaki O, Isobe Y, Nosaka S, Nakazawa A. J Pediatr Surg; 2011 Jun 20; 46(6):e19-22. PubMed ID: 21683186 [Abstract] [Full Text] [Related]
12. Successful portal-systemic shunt occlusion of a direct shunt between the inferior mesenteric vein and inferior vena cava with balloon-occluded retrograde transvenous obliteration following recanalization after placing a covered stent in the portal and superior mesenteric veins. Hayashi S, Baba Y, Senokuchi T, Ueno K, Nakajo M. Jpn J Radiol; 2009 May 20; 27(4):180-4. PubMed ID: 19499309 [Abstract] [Full Text] [Related]
15. Efficacy of balloon-occluded retrograde transvenous obliteration (B-RTO) performed in a patient with primary biliary cirrhosis with severe recurrent hepatic encephalopathy due to splenorenal shunt. Takashimizu S, Watanabe N, Kojima S, Kagawa T, Mine T, Myojin K, Koizumi J. Tokai J Exp Clin Med; 2007 Jul 20; 32(2):70-4. PubMed ID: 21319062 [Abstract] [Full Text] [Related]
17. Refractory and Severe Hepatogenous Diabetes in a Patient with Cirrhosis Improved by Balloon-Occluded Retrograde Transvenous Obliteration of a Large Portosystemic Shunt. Kasuya S, Hidemasa K, Yamaguchi T, Uchi T, Inaoka T, Terada H. Cardiovasc Intervent Radiol; 2021 Jun 20; 44(6):988-991. PubMed ID: 33709280 [Abstract] [Full Text] [Related]
18. [Successful balloon-occluded retrograde transvenous obliteration (B-RTO) in a case of symptomatic epilepsy with hepatic encephalopathy due to non-cirrhotic porto-systemic shunt]. Shibata A, Hayashi S, Noguchi M. Rinsho Shinkeigaku; 2005 May 20; 45(5):341-5. PubMed ID: 15960169 [Abstract] [Full Text] [Related]